Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer (Annals of Surgical Oncology, (2019), 26, 11, (3510-3516), 10.1245/s10434-019-07577-4)

Michael D. Alvarado; Elizabeth A. Mittendorf; Mediget Teshome; Alastair M. Thompson; Richard J. Bold; Mark A. Gittleman; Peter D. Beitsch; Sarah L. Blair; Kaisa Kivilaid; Quentin J. Harmer; Kelly K. Hunt

doi:10.1245/s10434-020-08688-z

Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer (Annals of Surgical Oncology, (2019), 26, 11, (3510-3516), 10.1245/s10434-019-07577-4)

Michael D. Alvarado, Elizabeth A. Mittendorf, Mediget Teshome, Alastair M. Thompson, Richard J. Bold, Mark A. Gittleman, Peter D. Beitsch, Sarah L. Blair, Kaisa Kivilaid, Quentin J. Harmer, Kelly K. Hunt

Surgery

Research output: Contribution to journal › Comment/debate

Abstract

In the original article the authors’ disclosures were incomplete. Following is the revised text: This clinical study was sponsored by Endomagnetics Inc., which provided funding to the institutions of all authors (K. Hunt PI). Dr. Michael D. Alvarado received travel support from Endomagnetics Inc. All other authors reported no conflicts of interest.

Original language	English (US)
Journal	Annals of Surgical Oncology
DOIs	https://doi.org/10.1245/s10434-020-08688-z
State	Accepted/In press - Jan 1 2020

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-020-08688-z

Fingerprint Dive into the research topics of 'Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer (Annals of Surgical Oncology, (2019), 26, 11, (3510-3516), 10.1245/s10434-019-07577-4)'. Together they form a unique fingerprint.

Cite this

Alvarado, M. D., Mittendorf, E. A., Teshome, M., Thompson, A. M., Bold, R. J., Gittleman, M. A., Beitsch, P. D., Blair, S. L., Kivilaid, K., Harmer, Q. J., & Hunt, K. K. (Accepted/In press). Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer (Annals of Surgical Oncology, (2019), 26, 11, (3510-3516), 10.1245/s10434-019-07577-4). Annals of Surgical Oncology. https://doi.org/10.1245/s10434-020-08688-z

Correction to : SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer (Annals of Surgical Oncology, (2019), 26, 11, (3510-3516), 10.1245/s10434-019-07577-4). / Alvarado, Michael D.; Mittendorf, Elizabeth A.; Teshome, Mediget; Thompson, Alastair M.; Bold, Richard J.; Gittleman, Mark A.; Beitsch, Peter D.; Blair, Sarah L.; Kivilaid, Kaisa; Harmer, Quentin J.; Hunt, Kelly K.

In: Annals of Surgical Oncology, 01.01.2020.

Research output: Contribution to journal › Comment/debate

Alvarado, MD, Mittendorf, EA, Teshome, M, Thompson, AM, Bold, RJ, Gittleman, MA, Beitsch, PD, Blair, SL, Kivilaid, K, Harmer, QJ & Hunt, KK 2020, 'Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer (Annals of Surgical Oncology, (2019), 26, 11, (3510-3516), 10.1245/s10434-019-07577-4)', Annals of Surgical Oncology. https://doi.org/10.1245/s10434-020-08688-z

Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA et al. Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer (Annals of Surgical Oncology, (2019), 26, 11, (3510-3516), 10.1245/s10434-019-07577-4). Annals of Surgical Oncology. 2020 Jan 1. https://doi.org/10.1245/s10434-020-08688-z

Alvarado, Michael D. ; Mittendorf, Elizabeth A. ; Teshome, Mediget ; Thompson, Alastair M. ; Bold, Richard J. ; Gittleman, Mark A. ; Beitsch, Peter D. ; Blair, Sarah L. ; Kivilaid, Kaisa ; Harmer, Quentin J. ; Hunt, Kelly K. / Correction to : SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer (Annals of Surgical Oncology, (2019), 26, 11, (3510-3516), 10.1245/s10434-019-07577-4). In: Annals of Surgical Oncology. 2020.

@article{8e88409614c94a59aab1634af99c11c3,

title = "Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer (Annals of Surgical Oncology, (2019), 26, 11, (3510-3516), 10.1245/s10434-019-07577-4)",

abstract = "In the original article the authors{\textquoteright} disclosures were incomplete. Following is the revised text: This clinical study was sponsored by Endomagnetics Inc., which provided funding to the institutions of all authors (K. Hunt PI). Dr. Michael D. Alvarado received travel support from Endomagnetics Inc. All other authors reported no conflicts of interest.",

author = "Alvarado, {Michael D.} and Mittendorf, {Elizabeth A.} and Mediget Teshome and Thompson, {Alastair M.} and Bold, {Richard J.} and Gittleman, {Mark A.} and Beitsch, {Peter D.} and Blair, {Sarah L.} and Kaisa Kivilaid and Harmer, {Quentin J.} and Hunt, {Kelly K.}",

year = "2020",

month = jan,

day = "1",

doi = "10.1245/s10434-020-08688-z",

language = "English (US)",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York",

}

TY - JOUR

T1 - Correction to

T2 - SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer (Annals of Surgical Oncology, (2019), 26, 11, (3510-3516), 10.1245/s10434-019-07577-4)

AU - Alvarado, Michael D.

AU - Mittendorf, Elizabeth A.

AU - Teshome, Mediget

AU - Thompson, Alastair M.

AU - Bold, Richard J.

AU - Gittleman, Mark A.

AU - Beitsch, Peter D.

AU - Blair, Sarah L.

AU - Kivilaid, Kaisa

AU - Harmer, Quentin J.

AU - Hunt, Kelly K.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - In the original article the authors’ disclosures were incomplete. Following is the revised text: This clinical study was sponsored by Endomagnetics Inc., which provided funding to the institutions of all authors (K. Hunt PI). Dr. Michael D. Alvarado received travel support from Endomagnetics Inc. All other authors reported no conflicts of interest.

AB - In the original article the authors’ disclosures were incomplete. Following is the revised text: This clinical study was sponsored by Endomagnetics Inc., which provided funding to the institutions of all authors (K. Hunt PI). Dr. Michael D. Alvarado received travel support from Endomagnetics Inc. All other authors reported no conflicts of interest.

UR - http://www.scopus.com/inward/record.url?scp=85086016373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086016373&partnerID=8YFLogxK

U2 - 10.1245/s10434-020-08688-z

DO - 10.1245/s10434-020-08688-z

M3 - Comment/debate

AN - SCOPUS:85086016373

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

ER -